Certified Midwife Exam Prep Pharmacology & Medications in Midwifery 3

Question 1

For treatment of postpartum hemorrhage, how should oxytocin be administered to avoid cardiovascular side effects?

Accepted Answer

10–40 IU diluted in IV fluid as a controlled infusion

Answer

10 IU rapid IV bolus undiluted

Answer

20 IU single intramuscular injection

Answer

5 IU subcutaneous injection every 30 minutes

Question 2

A breastfeeding patient develops mastitis. Which antibiotic class is generally avoided due to concerns about infant cartilage development?

Accepted Answer

Fluoroquinolones

Answer

Penicillins

Answer

Cephalosporins

Answer

Macrolides

Question 3

A patient receiving both nifedipine (tocolysis) and magnesium sulfate (seizure prophylaxis) should be monitored for which drug interaction?

Accepted Answer

Enhanced neuromuscular blockade and excessive hypotension

Answer

Increased uterine contractility

Answer

Reduced seizure threshold

Answer

Increased risk of postpartum hemorrhage

Question 4

What is the recommended daily dose of folic acid for a woman of childbearing age to prevent neural tube defects?

Accepted Answer

Folic acid 400–800 mcg/day

Answer

Vitamin D 2000 IU/day

Answer

Iron 30 mg/day

Answer

Vitamin B12 1000 mcg/day

Question 5

A neonate delivered 4 hours after maternal meperidine administration presents with respiratory depression. Which medication should be given?

Accepted Answer

Naloxone 0.1 mg/kg IM/IV

Answer

Epinephrine 0.01 mg/kg IV

Answer

Atropine 0.02 mg/kg IV

Answer

Flumazenil 0.01 mg/kg IV

Question 6

Antenatal corticosteroids are administered to a patient at 32 weeks with threatened preterm labor. What is the primary therapeutic goal?

Accepted Answer

Acceleration of fetal lung surfactant production

Answer

Suppression of preterm uterine contractions

Answer

Treatment of underlying maternal infection

Answer

Reduction of maternal blood pressure

Question 7

When reviewing a medication's FDA pregnancy category, which category indicates that animal studies have demonstrated fetal risk and adequate human studies are lacking, but potential benefits may warrant use?

Accepted Answer

Category C

Answer

Category A

Answer

Category B

Answer

Category D